Macrocyclic indoles as hepatitis C virus inhibitors

Details for Australian Patent Application No. 2008339917 (hide)

Owner Tibotec Pharmaceuticals

Inventors Raboisson, Pierre Jean-Marie Bernard; Hu, Lili; Vendeville, Sandrine; Nyanguile, Origene

Agent Shelston IP

Pub. Number AU-A-2008339917

PCT Pub. Number WO2009/080836

Priority 07150415.3 24.12.07 EP

Filing date 23 December 2008

Wipo publication date 2 July 2009

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 513/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/080836 Priority application(s): WO2009/080836

28 April 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Raboisson, Pierre Jean-Marie Bernard; Hu, Lili; Vendeville, Sandrine; Nyanguile, Origene and Tahri, Abdellah

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339918-Medicament for the treatment of cancer of the pancreas

2008339913-Methods and agents for improving targeting of CD138 expressing tumor cells